video corpo

Corporate Guide
22Pages

{{requestButtons}}

Catalog excerpts

Corporate Guide - 2

© Courtesy of the Kitasato Institute archives Terumo Corporation was founded in 1921 by several scientists and doctors, including Dr. Shibasaburo Kitasato, to produce clinical thermometers in Japan. These vital medical devices had previously been imported, until they were cut off as a consequence of World War I. The lifelong spirit of Dr. Kitasato, whose achievements received global recognition, is found in his statement: “Scientists should never feel self-satisfaction doing advanced research; the true objective is for the results to be put to use, thereby contributing to society.”...

Open the catalog to page 2
Corporate Guide - 3

Corporate Mission Contributing to Society through Healthcare We contribute to society by providing valued products and services in the healthcare market and by responding to the needs of patients and healthcare professionals. Five Statements Open Management: We maintain a fundamental policy of open management, work to secure and return to our benefactors a suitable profit, and strive to develop our business on a global basis as befits a leading company in the industry. Enhanced Value: We emphasize the importance of scientific thinking, creativity, and time appropriation, and respond in...

Open the catalog to page 3
Corporate Guide - 4

Feature Article: Rising to the Challenge of Innovation TERUMO CORPORATION Corporate Guide

Open the catalog to page 4
Corporate Guide - 5

Getting Patients with Cardiovascular Disease Back to Daily Life as Quickly as Possible “I was able to get back to daily life in only a week. I go to work, I drive, and now I can go for walks, too.” Josias lives in a suburb of São Paulo, Brazil. A routine physical exam in December 2013 found one of his coronary arteries to be blocked by cholesterol and other substances that were preventing sufficient blood flow. In March 2014, Josias underwent an interventional procedure, in which a thin tube, called an interventional device, was used to open up the blocked artery from the inside and restore...

Open the catalog to page 5
Corporate Guide - 6

Feature Article: Rising to the Challenge of Innovation TERUMO CORPORATION Corporate Guide

Open the catalog to page 6
Corporate Guide - 7

Systems that Enhance Safety for Medical Professionals Handling Anticancer Drugs In cancer chemotherapy, anticancer drugs are used to suppress the proliferation of cancer cells. Anticancer drugs, however, not only destroy cancer cells, they also have side effects that damage normal cells and can cause serious health problems. These include leukemia and infertility in healthy people, and congenital birth defects. It has been pointed out that these health risks are a particular concern for the pharmacists and nurses who prepare anticancer drugs and administer them to patients as a normal part...

Open the catalog to page 7
Corporate Guide - 8

Feature Article: Rising to the Challenge of Innovation TERUMO CORPORATION Corporate Guide

Open the catalog to page 8
Corporate Guide - 9

Providing Safer Blood Products to Patients in Developing Nations In Africa, blood products used for transfusions often contain residual white blood cells and pathogens such as viruses and bacteria. For example, in Ghana, 10 to 15% of whole blood products are contaminated by bacteria and 50% contain malaria (plasmodium) parasites. For Africa as a whole, the WHO estimates that 5 to 10% of new HIV infections are due to unsafe blood. At a global level, the World Health Organization (WHO) believes that better blood safety strategies could prevent 160,000 new cases of HIV annually. While testing...

Open the catalog to page 9
Corporate Guide - 10

Rising to the Challenge of Innovation Koji Nakao Chairman and Representative Director TERUMO CORPORATION Corporate Guide Yutaro Shintaku President and Representative Director

Open the catalog to page 10
Corporate Guide - 11

With our corporate mission of “Contributing to Society through Healthcare,” we work proactively to stably provide high-quality medical devices and services for the benefit of patients and medical settings in over 160 countries, while also developing solutions to advance the practice of healthcare. Today, various social conditions are causing a diversification of needs in healthcare. Terumo is responding to these changes by developing and providing devices and systems that enhance safety and efficiency while also improving patient comfort. Recognizing that the benefits of medical devices are...

Open the catalog to page 11
Corporate Guide - 12

Business Overview Terumo is Rising to the Challenge to Innovate in Three Business Areas Terumo is “contributing to society through healthcare” by pursuing business activities through three companies. We provide optimal products and services to medical settings the world over. In pursuing higher quality in medicine, we introduce improvements for greater safety and ease of use, conduct training to promote proper usage of devices, and propose systems for responding comprehensively to the needs of medical settings. Blood Management Company Pharmaceutical and Nutrition Division 141.3 billion yen...

Open the catalog to page 12
Corporate Guide - 13

Cardiac & Vascular Company The Cardiac & Vascular Company strives to make interventional procedures and surgery for treating heart and other types of vascular diseases less burden on patients When cholesterol and other substances build up on the inside walls of blood vessels due to causes including lifestyle diseases, they can eventually result in heart attacks or angina. These can be treated by using an intervention device to open up a blocked blood vessel from the inside, in what is known as coronary intervention, or surgically opening up the chest and using a section of blood vessel from...

Open the catalog to page 13
Corporate Guide - 14

Business Overview Cardiac & Vascular Company The Cardiac & Vascular Company contributes to cutting-edge treatments including cardiac and vascular surgery, and interventional procedures performed inside blood vessels Pursuing Therapies that Minimize Physical Burden on Patients Interventional Therapy Performed from a Blood Vessel in the Wrist (TRI) To further reduce physical burden on patients when performing interventional therapies, an increasing number of practitioners have in recent years adopted an approach that gains blood vessel access at the wrist, rather than the groin. Terumo offers...

Open the catalog to page 14
Corporate Guide - 15

Optimizing Cardiovascular Surgery Applying Interventional Techniques Approaches to Perform Therapies for the Entire Body The Cardiac & Vascular Company uses technologies for coronary intervention to expand its line of products for performing neurovascular intervention therapies and peripheral intervention for the lower extremities. Neurovascular Intervention (Cerebral Blood Vessels) Cardiopulmonary Bypass System The Cardiac & Vascular Company provides artificial vascular grafts used in cardiovascular surgery, and systems that temporarily perform the functions of the heart and lungs during...

Open the catalog to page 15

All Terumo BCT catalogs and technical brochures

  1. Quantum

    2 Pages

  2. SCD® IIB

    6 Pages

  3. TSCD® -Q

    6 Pages

  4. COBE® 2991

    4 Pages

  5. TSCD®-II

    12 Pages

  6. Reveos®

    16 Pages

  7. Mirasol®

    7 Pages

  8. TSCD-II

    12 Pages

  9. IMUFLEX CGQ

    2 Pages

  10. TSCD® II

    12 Pages

  11. Cadence®

    1 Pages